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Abstract
Context: The current study aimed to review research articles concerning kinesin-1 traffic control in the neuronal highways
Evidence Acquisition: This review article compromised previous studies published since 1980 using PubMed, Google scholar, Em-
base, Medline, science direct and SID databases according to the keywords.
Results: Kinesin-1 often recognizes scaffold proteins or adaptor proteins and binds to cargo membrane proteins directly as part of
a protein complex. Several kinases and microtubule associated proteins are identified in the regulation of motor-cargo unloading.
The mechanisms by which kinesin-1 recognizes and binds to specific cargos, and how to unload cargo and determine the direction
of transport, are now identified.
Conclusions: In summary, the current review article demonstrated that some proteins such as adaptors, Scaffolds, chaperons and
microtubule associated proteins and some metabolites, hormones, protein kinases and exercise training can regulate kinesin-1 traf-
fic control in neuronal highway. These findings open exciting new areas of kinesin-1 research.
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1. Context
Molecular traffic in mammals in a fine designed neu-
ral system is dedicated to molecular motors. Basically,
this traffic is done by dynein and kinesin superfamily pro-
teins. These molecular motors use high polarized struc-
ture of neurons to perform their duty (1). Among neu-
ronal cytoskeleton main elements, only microtubules and
actin filaments play an important role in supplying neu-
ronal elaborated tracks. Molecular motors ultimately use
microtubules organization in a polarized array for tar-
geted transport of substances (1, 2). Whereas axonal mi-
crotubules are uniformly organized with the plus end di-
rected toward the axonal terminals and minus end di-
rected toward the soma, but dendritic microtubular po-
larization is mixed in orientation. Mostly, kinesins and
dynein motor proteins use this polarization for antero-
grade and retrograde transport of cargos, respectively (1).
So far, 45 kinesin genes are recognized in mammals that
constitute 15 kinesin super families. Moreover, depending
on the location and position of the kinesins motor domain,
all 15 kinesin super families can be grouped in to three
types: M-kinesins are involved in microtubules depolymer-
ization; N-kinesins are plus end-directed and C-kinesins are
minus end-directed (2, 3).
2. Evidence Acquisition
Kinesin-1 classified as an N-kinesin was the first identi-
fied kinesin motor protein in neuronal microtubule-based
motility system and its roles and functions are well docu-
mented (4). In its structure, kinesin-1 has two heavy and
two light chains. The motor role of kinesin-1 is dedicated
to its two heavy chains known as KIF5 that use ATP as a fuel
to generate the movement of kinesin-1 along with micro-
tubules. Until now, three subtypes of KIF5 are discovered
in mammals: KIF5A, KIF5B and KIF5C (1) (Figure 1). The N-
terminal motor domain of each KIF5 can bind directly to
microtubules and facilitate kinesin-1 directional motility.
On the other hand, its C-terminal is involved in the associa-
tion between KIF5 and kinesin light chains or direct attach-
ment with intracellular cargo vesicles (1, 2). The current re-
view focused on several important aspects of kinesin-1 reg-
ulation.
3. Results
3.1. Self-Regulation as an Intelligent Molecular Motor
To prevent futile ATP consumption/hydrolysis and
heavy traffic in microtubular tracks in the neuronal cells
kinesin-1 takes a folded shape as an auto-inhibition mech-
anism for the precise regulation in the presence of cargo,
released from auto-inhibition and takes an active shape
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Figure 1. The Domain Structure of Knesin-1
Phylogenetic structures of kinesin-1 genes are classified into KIF5A, KIF5B, and KIF5C.
In general, kinesin-1comprises a kinesin motor domain and a coiled-coil domain.
(5) (Figure 2). Moreover, microtubular stability and po-
larity are among the two most important aspects of ax-
onal transport. Evidence shows that kinesin-1 can regulate
microtubular stability and polarity. It was shown that in-
vitro kinesin-1 directly binds to microtubules and mediates
their gliding (6). Recent findings show that by gliding mi-
crotubules toward the plus-end-out in dendrites, kinesin-
1 can regulate dendritic microtubular stability and polar-
ity (7). Generally these findings indicate that kinesin-1 is in-
volved in intracellular cargo traffic control by changing its
shape in its rail road.
Figure 2. Intracellular Transport by Kinesin-1 Motor Protein in Neurons
A, unipolar microtubules in neuronal axons, and mixed directionality of micro-
tubules is in proximal dendrites. In neuronal axons, microtubules are unipolar and
the plus ends always point distally. Therefore, kinesin-1 as plus end-directed motors
transports specific cargos to the cell periphery in axons. B, auto-inhibition mech-
anism for the kinesin-1 in the presence of cargo. In the absence of cargo, kinesin-
1motors are auto-inhibited which assume a folded conformation that enables an
inhibitory and direct motor-to-tail interaction (left). But, auto-inhibition state of
kinesin-1 motors can be relieved by the interaction with cargoes (right).
3.2. Role of Microtubule Associated Proteins
Although the duty of axonal transport is dedicated to
motor proteins, this event may be affected by microtubule
associated proteins (MAPs) (8). MAPs are a distinct group
of proteins thought to play an important role in mediating
microtubule assembly and stability by binding to the tubu-
lin. Among a large variety of identified MAPs, MAP2 as well
as tau can inhibit the binding of kinesin-1 to microtubules
and thereby lead to disrupted axonal transport (9). MAP4
is another MAP isoform that in contrast to MAP2 does not
compete with kinesin-1 to bind to microtubules, but acts as
roadblocks and can stop kinesin-1 motility by altering mi-
crotubular properties (10). Also, tau as a MAP is involved
in the stabilization of microtubules. Evidence shows that
excessive tau phosphorylation inhibits kinesin-1-driven ax-
onal transport of vesicles, mitochondria, and endoplasmic
reticulum attributed to the Alzheimer’s disease pathology
(11, 12). The plus end interacting protein (+TIP) EB1 as a
MAP can increase microtubule stiffness and slow kinesin-
1 motility (13).
Prion protein (PrP) is a misfolded form of natural
proteins existing in cellular membranes of brain neu-
rons and other types of cells and plays an important role
in the pathogenesis of numerous neurodegenerative dis-
eases. Hence, direct interaction with tubulin, PrP leads
to its oligomerization/aggregation and finally inhibits mi-
crotubule assembly in-vitro and impairs kinesin-1 driven
transport (14). Moreover, recent work in Drosophila S2 cells
showed that ensconsin is an MAP kinesin-1 released from
auto-inhibited state required for kinesin-1 organelle trans-
port (15).
3.3. The Role of Adaptor Proteins
By integration of multiple signaling pathways, mam-
malian cells can response appropriately and specifically to
external stimulus. Once cell surface receptors are stimu-
lated, post-translational modifications such as phospho-
rylation leads to cellular signals initiation which require
some modifications including specific protein binding to
specific subcellular domains. In cell biology, adaptor pro-
teins are an emerging class of proteins involved in all of the
aforementioned processes (16). Due to the important role
of kinesin-1 in neuronal signaling pathways, adaptor pro-
teins are one of the major regulators of this motor protein.
Collapsin response of mediator protein-2 (CRMP2) is
enriched in brain neurons that can regulate neuronal mi-
crotubule assembly. In addition to the growth cone dy-
namic (17) and neurite outgrowth regulation (18), CRMP2
also leads to kinesin-1-dependent tubulin transport in the
developing neurons by binding to KLC1 (19). Also, caytaxin
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is an adaptor protein that plays an important role in cere-
bellum function and its deficit leads to ataxia (20) and dys-
tonia (21). Caytaxin can bind to KLC1 and modulate intracel-
lular transport of specific cargoes such as mitochondria in
hippocampus neurons (22).
Also, portrudine as an adaptor protein can facilitate
kinesin-1 interaction with Rab-11, VAP-A, VAP-B, surf4, and
RNT3 and protrudine-kinesin-1 complex contributes to the
axonal anterograde vesicular transport of these proteins
in mouse brain (23). The S100 protein family Ca2+-binding
proteins are in cytoplasm of different cells and are involved
in multiple cell processes such as cell cycle progress and
differentiation. It is shown that S100A2 and S100A6 in a
Ca2+-regulated fashion can bind to tetratricopeptide (TPR)
domains of KLC. Moreover, S100A6 can inhibit KLC- (JNK)-
interacting protein 1 (JIP-1) interaction (24). DAXX death re-
lated protein is one of the FAS ligand interacting proteins
that can acts as a protein interaction modulator and acti-
vates JNK and apoptosis in different cell functions. Also,
DAXX can interact with Glut-4 (25) and Glut-4 is one of
the kinesin-1 cargoes transported along with microtubules
(26). Recent evidence showed that DAXX, as an adaptor pro-
tein, interacts with KLC-TPR domain and plays an impor-
tant role in cargo transport at adipose cell tissues (27).
Kidins220 (kinase D-interacting substrate of 220 k Da)
is an integral membrane protein which exists in highly
plastic areas of the adult brain neurons and plays an im-
portant role in developing the nervous system (28-30).
Kidins220 can interact with KLC1 and facilitate kinesin-1-
dependent transport linked to neurotrophin action (22).
Moreover, Kidins220 can regulate neuronal polarity (31) by
interaction with tubulin and MAPs. The 14-3-3 proteins are
a family of proteins that participate in the regulation of
a wide range of biological processes such as signal trans-
duction, cell cycle, transcription, apoptosis, and neuronal
development (32). These proteins can attach to phospho-
rylate Huntingtin-associated protein (1HAP1) and reduce
KLC2-HAP1 interaction (33). Elongation protein zeta 1 (FEZ1)
is another specific kinesin-1 adaptor protein that facilitates
syntaxin 1 (syntaxin) and synaptotagmin (34) axonal trans-
port. Although, RAN binding protein 2 (RANBP2) can ap-
proximately increase ATPase activity of KIF5B by 30 folds in
the presence of ATP and microtubules, it induces unfold-
ing and inactive shape of KIF5B (35) in the absence of mi-
crotubules.
3.4. The Role of Scaffold Proteins
Scaffold proteins are known as a regulator of many cel-
lular signaling pathways that play an important role in sig-
nal transduction by interacting with multiple members of
a signaling pathway. The role of c-jun NH2-terminal kinase
(JNK)-interacting proteins (JIPs) JIP-1, JIP-2, JIP-3 and JIP-4,
which are scaffolding proteins for the JNK signaling path-
way in kinesin-1 regulation, are well documented (36). TPR
domain of KLC can interact with JIP-1 (37), JIP-2, JIP3 (38),
JIP-4 (39), JNK-associated leucine zipper protein (JLP) (40),
Torsin A (41), HAP1 (42) and calsytenin-1 (43). Recent evi-
dence show that JIP-1 cannot directly play a role in kinesin-
1-cargo attachment and this event is dependent on the in-
teraction between JIP-3 and PTB (phosphotyrosine bind-
ing) domains of kinesin-1 (44). Also, JIP-1 plays an impor-
tant role in the attachment of apolipoprotein E receptor
2 (APOER2) cargos with kinesin-1 (36), Similar to other JIPs,
JLP can assemble JNK signaling (45) through upstream ki-
nases such as MKK4 and MEKK3.
3.5. Role of Chaperon Proteins
Environmental stress leads the cells to change their ex-
pression program, which almost all of these genes include,
that encode heat shock proteins (Hsps). These proteins
act as molecular chaperones and play an important role
in a wide range of cellular processes including preventing
from unwanted interactions between unfolded polypep-
tides during their synthesis or transport, irreversible ag-
gregation of proteins, and refolding denatured proteins
(46). According to their molecular weights, Hsps fam-
ily can be divided and Hsp40, Hsp60, Hsp70, Hsp90, and
Hsp100 are the most important Hsps until today (47).
It was found that among different chaperone proteins,
both Hsp70 and Hsp110 interact with tubulin subunits.
Moreover, KLC1 can attach to Hsp70 and Hsp110 (48) and
these findings shows that chaperone proteins are involved
in neuronal transport. For better understanding the role
of Hsp70, it was shown that it plays an important role in
axonal transport of synaptic vesicles by releasing kinesin-
1 from cargo in specific subcellular domains (49). Also,
Hsp70 can partially rescue a vesicle transport defect pro-
duced by an ALS disease model, while Hsp110 completely
rescued this problem (50).
3.6. Regulation Depending on Different Gene Expression Pat-
terns
Variety of kinesin in different tissues of mammalian,
especially in neuronal cells, represents their different re-
sponsibilities in any type of cells. Authors previously
demonstrated that diabetes increases KIF5B mRNA and
protein levels and exercise endurance can modify it in
spinal cord (51). Silverman et al. investigated the gene ex-
pression of twenty kinesins super family members in em-
bryonic and adult hippocampal tissue cultures. Their re-
sults showed that kinesin-13, involved in microtubule de-
polymerization, is expressed in hippocampal neurons at
high levels and kinesin-9 and -14 family members, which
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their functions are not elucidated yet, are expressed at
moderate-to-high levels. While in embryonic hippocam-
pus 10 mitotic kinesins were expressed at moderate levels,
in mature cultures and the adult hippocampus their ex-
pression patterns were at very low levels (52). In agreement
with this finding, Takemura et al., showed that after sci-
atic crush injury, kinesin-1 and KIF1B gene expression lev-
els were 50% - 80% of the control in dorsal root ganglion
neuron (DRG) (53). Collectively, these findings suggest that
according to the diverse functions within a single type of
neuron, expression patterns of kinesins super family mem-
bers could be changed and they can adapt to the cell needs.
3.7. Role of Metabolites
Kinesin super families can move along microtubules
and transport their cargoes by generating about 6 pN of
force at a speed of about 1 µm s-1 with about 50% efficiency
from hydrolysis of ATP (54). After ATP hydrolysis at KHC, Pi
is released in one head of kinesin and after that in the other
head ADP could be released. This is exactly the mechanism
to explain the hand-over-hand pattern for kinesin move-
ment along microtubules (55). Therefore, it seems that ATP
hydrolysis rate and amount can affect kinesin function and
movement. Evidence showed that ATP low and high con-
centrations lead to weak and strong force production of ki-
nesin, respectively (56). On the other hand, while kinesin
run length is independent of ATP concentration, elevated
ADP concentration decreases both velocity and run lengths
(57). These findings suggest that kinesin movement prop-
erties are depended on the ATP concentration and hydrol-
ysis. Neurons are very sensitive to pH > 7.5; therefore,
kinesin-cargo interaction may have a pH-dependent man-
ner. Kinesin-dependent motility and transport increased
upon acidification in neuronal cells (58). Elevated temper-
ature and MG2+/ATP ratio are other metabolites-dependent
speed (59).
3.8. Role of Hormones
The human pro-adrenomedullin protein directs post-
translational modifications and finally leads to production
of two biologically active peptides: adrenomedullin (AM)
and pro-adrenomedullin N-terminal 20-peptide (PAMP)
(60). These peptides are known as a regulator of many
physiological processes including vasodilatation; bron-
chodilatation; hormone secretion regulation; antimicro-
bial activities; and modulation of cell growth, apoptosis,
migration, and angiogenesis (61). In addition to their ex-
tracellular roles, they can interact with the microtubules
in especial cell types (62). While AM can bind to MAPs,
PAMP directly interacts with tubulin and kinesin-1 and
postpones tubulin polymerization (62). Recent evidence
shows, in-vitro and in-vivo, that PAMP can directly interact
with kinesin-1 and increase its velocity along microtubules
and ATPase activities (63). The current study suggests that
PAMP is a first peptide that can regulate kinesin-1 motility.
3.9. The Role of Protein Kinases
Protein kinases participate in a variety of functions,
including signal transduction, regulation of ion channels
and neurotransmitter release, control of cell growth and
differentiation, and changes in cell morphology and gene
expression (64, 65). Protein kinase A (PKA)-dependent
phosphorylation of KIF5-KLC complex, inhibits kinesin-1
from binding to synaptic vesicles (66). Also, glycogen
synthase kinase 3 inhibits the interaction between KIF5-
KLC complexes and membrane organelles (67) by phos-
phorylation of KLC in the same manner. In addition, as
a protein kinase JNK can phosphorylate KIF5 motors (37,
68) and thereby leads to weak motor–microtubule asso-
ciations (40). Moreover, abnormal activation of JNK sig-
naling pathway disturbs axonal transport (36) by detach-
ment of kinesin-cargo associations. Also, protein kinases
can regulate microtubular stability and polarity. In this re-
gard, glycogen synthases kinase 3β (GSK3β)-induced phos-
phorylation disturb microtubular stability (69). In addi-
tion, GSK3β can phosphorylate tau, MAP2, MAP1B, CRMP2,
APC and axin (47, 70). Cyclin-dependent kinase (Cdk5) is
another protein kinase that can phosphorylate tau, regu-
late microtubular stability and kinesin-1 localization (71).
In addition, GSK3β can directly phosphorylate the KlC
subunit of a kinesin-1 motor and decrease its association
with membrane-bound organelles (5). Authors previously
showed that decreased activity and tight ligation of the
L5 spinal nerve in neuropathic pain rats cause muscle de-
crease and increase in CDK5 and GSK-3β mRNA levels, re-
spectively and these changes are followed by pain-related
disorders and soleus muscle atrophy (64).
3.10. The Role of Cargoes
Members of the kinesin-1 family drive the transport of
a wide range of cargos along the axon including vesicles,
organelles, proteins and RNA particles. The light chains
contain tetratricopeptide repeat protein-interaction mo-
tifs (TPRs), which can dock onto adaptors or cargo recep-
tors, linking kinesin-1 to the cargo to be transported (1). It
is possible that the cargoes transported by kinesin regulate
kinesin-mediated transport. Alcadeinα (Alcα) is an evolu-
tionarily conserved type I membrane protein expressed in
neurons. Alcα can be transported by kinesin-1 with slower
speed than ATP containing vesicles. Moreover, Alcα can
bind vesicles to kinesin-1 and regulate kinesin-cargo inter-
action. Also, Alcα can activate kinesin-1 or block transport
4 Biotech Health Sci. 2016; 3(2):e35914.
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of APP-containing vesicles (72) by direct interaction with
KLC. Coordination of kinesin-1 needs to be highly regu-
lated. Many lines of evidence support the view that kinesin-
1-mediated transport is modulated by phosphorylation of
the motor proteins or the cargoes. Kinesin phosphoryla-
tion on serine residues correlates with cargo binding in
cultured cells, whereas the release of kinesin from vesi-
cles correlates with the phosphorylation of KLC by glyco-
gen synthase kinase 3β (GSK3β), which acts as an inhibitor
of fast anterograde transport (1, 2, 64, 73). In addition, hy-
perphosphorylation of tau by GSK3β or CDK5 reduces its
affinity for microtubules and its ability to promote micro-
tubule assembly and modulates its ability to stabilize mi-
crotubules into organized arrays in-vitro (2, 74). These find-
ings suggest that many aspects of kinesin-1 regulation may
depend on the interaction between motor proteins and
cargoes.
3.11. The kinesin-1 and Neurodegenerative Diseases
Maintenance and function of neurons are dependent
on the intracellular transport of organelles along the ax-
ons. Basically, having a good synaptic function and mi-
tochondria for local energy requirements in neurons are
dedicated to molecular motor proteins that anterogradely
transport cargoes (1). Neurodegenerative diseases are char-
acterized by significant defects in synaptic function and
dying-back degeneration of axons (1, 75). Accordingly, al-
terations in fast axonal transport are documented in the
Alzheimer, Parkinson And Huntington diseases and amy-
otrophic lateral sclerosis (1, 2). These diseases are associ-
ated with mutations/dysfunctions in molecular motor pro-
teins or alterations in the activity of specific protein ki-
nases implicated in regulation of these motor proteins’
function (2, 68). For example, mutation in KIF5A results
in a hereditary form of spastic paraplegia, a disease char-
acterized by progressive dysfunction and degeneration of
upper motor neurons (76). Moreover, kinesin mutations
are caused by Charcot-Marie-Tooth (CMT) disease (77). In
agreement with these studies, authors previously showed
that diabetic neuropathy state changed neuronal kinesin-
1 motor protein and endurance exercise training modified
this change (51). Generally, it can be noticed that molecular
motor proteins and their regulator seem to be the target of
neurodegenerative diseases.
3.12. Kinesin-1 and Exercise Training
Previous studies showed that treadmill exercise train-
ing can improve peripheral nervous tissue regeneration
after nerve injury and increases axonal regeneration after
sciatic nerve transection (78, 79). Exercise training is an in-
teresting model which increases activation of sensory and
motor neurons, axonal transport of proteins, and synaptic
remodeling (51, 79). Authors previously demonstrated that
diabetic neuropathy changes spinal cord KIF5B and SYD
mRNA and sciatic nerves KIF5B content and exercise train-
ing modifies it, which may be attributable to the training-
induced decreased hyperglycemia. These studies proved
that exercise training increases the quantity of axonal pro-
teins and axonal transport. Moreover, the results showed
that exercise training, as a neuroprotective strategy, can in-
crease kinesin-1 levels in lumbar sensory and motor neu-
rons. The researches in the field of axonal transport im-
pairments in neurodegenerative diseases may be support-
ive of cargo and driver theory (51). This theory explains that
in neurodegenerative diseases, down-regulation of neu-
rotrophic factors and other proteins essential for neuronal
survival. Also, impairment in motor proteins transports
these cargoes actively (51). Another important issue related
to this theory refers to the modifying role of exercise. How-
ever, there are other related points which should be ex-
plained by future studies.
Figure 3. The Role of MAPs in Kinesin-1 Regulation
At the point of departure, motor–cargo complexes should navigate microtubule
tracks. MAPs bind to the outer surface of microtubules and can cause decreased at-
tachment and/or increased detachment of kinesin-1 motors and/or vesicles. Trans-
port of kinesin-1-driven can be influenced by some MAPs such as tau, MAP1, MAP4,
ensconsin, and PrP (top panel, left part). This event can be negatively influenced by
the tau and MAP2 which can inhibit the binding of kinesin-1 to microtubules and
thereby lead to disrupted axonal transport. In addition, MAP4 acts as road blocks
and can stop kinesin-1 motility by altering microtubular properties. In contrast, en-
sconsin released kinesin-1 from auto-inhibited state (top panel, right part). More-
over, PrP leads to oligomerization/aggregation of tubulin and finally inhibits a mi-
crotubule assembly. The down part shows that some MAPs such as EB1 can increase
microtubule stiffness and slow kinesin-1 motility.
4. Conclusions
The role of kinesin-1 in the development of axonal
transport is well established, while the knowledge of in-
volved regulatory mechanisms is rapidly growing. Future
studies are required to elucidate how spatial information
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Figure 4. Adaptor Proteins and Kinesin-1 Transport
Adaptor proteins are needed to attach cargo to kinesin-1. Auto-inhibition of kinesin-
1 motors can be relieved by the interaction with adaptor proteins that release the
restraints of microtubule binding and processive motility.
Figure 5. ATP and ADP Concentration in Kinesin-1 Regulation
High concentrations of ATP lead to strong force production of kinesin. On the other
hand, high concentrations of ADP lead to weak force production of kinesin.
inside cells and signals outside cells regulate kinesin-1 and
address what signals control the association and dissocia-
tion of kinesin-1 and cargos, thereby controlling neuronal
transport. Furthermore, Future studies will reveal how
kinesin-1 recognizes cargos, scaffold and adaptor proteins.
Better understanding of these pathways would help im-
prove the preventive, predictive, and therapeutic interven-
tions in neurodegenerative diseases.
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